Clover Carroll

Christ is King, Director Of The White Rose Resistance, There was no insurrection, Covid-19 was man made. We want justice. Hospital Protocols killed my mother.

[Clover Carroll @CloverCarroll]

@nicksortor Brix

[Clover Carroll @CloverCarroll]

@nicksortor Anthony Fauci, Rochelle Olinski, Dr. bricks (scarf lady) et al should be in prison. Nuremberg trials now! Let’s make public hangin’ great again.

[Clover Carroll @CloverCarroll]

Anthony Fauci, Rochelle Olinski, Dr. bricks (scarf lady) et al should be in prison. Nuremberg trials now! Let’s make public hangin’ great again.

[Clover Carroll @CloverCarroll]

Arrest Anthony Fauci now! And throw in PETER Hote, Rochelle, Olinski, the scarf lady aka Dr Brice, et al in prison. Nuremberg trials now, please! Make public hangings Great again.

[Clover Carroll @CloverCarroll]

@Protestia I hate to use such harsh language, but this guy is a cotton headed ninny muggins.

[Clover Carroll @CloverCarroll]

Well I guess the Biden FDA was wrong about ivermectin after all.

[Nicolas Hulscher, MPH @NicHulscher]

🚨BREAKING: Largest Real-World Study of Ivermectin + Mebendazole in Cancer Patients Shows 84.4% Clinical Benefit — Nearly HALF Report Cancer Disappearance or Tumor Regression

After just 6 months, 48.4% of cancer patients taking ivermectin and mebendazole reported NO EVIDENCE OF DISEASE (32.8%) or tumor regression (15.6%), while 36.1% reported disease stabilization⬇️

We have completed the largest real-world human analysis to date evaluating ivermectin and mebendazole in cancer patients—and the results represent one of the most compelling clinical signals ever documented for repurposed anti-parasitic therapies in oncology.

The groundbreaking analysis was made possible through a unique collaboration between The Wellness Company, the McCullough Foundation, and the Chairman of the President’s Cancer Panel (Dr. Harvey Risch)—uniting real-world clinical data, frontline medical experience, and high-level epidemiologic expertise to deliver urgently needed insights in oncology.

This was a real-world prospective clinical program evaluation of 197 cancer patients, with 122 completing a follow-up survey at about six months (61.9% response rate).

Cancer patients were prescribed compounded ivermectin–mebendazole, with each capsule containing 25 mg ivermectin and 250 mg mebendazole—most commonly taken at 1–2 capsules per day.

The cohort represented a clinically relevant population, including a wide variety cancer types, with 37.1% of patients reporting actively progressing disease at baseline and many having already undergone chemotherapy, radiation, and surgery.

At six months, 84.4% of cancer patients reported clinical benefit (Clinical Benefit Ratio: 84.4% [95% CI: 77.0–89.8%]):

✅ 32.8% reported no evidence of disease (95% CI: 25.1–41.5%)
✅ 15.6% reported tumor regression (95% CI: 10.2–23.0%)
✅ 36.1% reported stable disease (95% CI: 28.1–44.9%)

Treatment adherence was high, with 86.9% completing the full protocol and 66.4% remaining on therapy at six months.

The regimen was well tolerated, with 25.4% reporting side effects, primarily mild and gastrointestinal, and over 93% continuing treatment despite these events.

Patients were treated in real-world conditions alongside concurrent therapies, including chemotherapy (27.9%), radiation (21.3%), surgery (19.7%), supplements (49.2%), and dietary modification (37.7%), supporting use as an adjunctive approach.

Together, these findings represent a large, internally consistent real-world clinical signal that supports URGENT further investigation of ivermectin and mebendazole as low-toxicity, adjunctive cancer therapies.

Given the strength of the signal observed here, advancing this line of investigation is no longer optional—it is necessary.

This is NOT the end. We will continue advancing this work with larger datasets to further define and validate the role of anti-parasitics in cancer outcomes.

The manuscript is now available as a preprint on the Zenodo research repository, operated by the European Organization for Nuclear Research, while undergoing peer review at leading oncology journals: “Real-World Clinical Outcomes of Ivermectin and Mebendazole in Cancer Patients: Results from a Prospective Observational Cohort.”

@twc_health @McCulloughFund @P_McCulloughMD @DrHarveyRisch @DrKellyVictory @jathorpmfm @drdrew @PeterGillooly @FosterCoulson

[Clover Carroll @CloverCarroll]

@EricLDaugh @AJHurleyLife Why was this marked as sensitive content @ElonMusk round these traitors up and put them in prison.

[Clover Carroll @CloverCarroll]

This is not a good look Mr President.

[Clover Carroll @CloverCarroll]

@5solas This is blasphemy.

[Clover Carroll @CloverCarroll]

@goddek @AngelaBelcamino No he didn’t

[Clover Carroll @CloverCarroll]

@TheLibertyCall https://t.co/8TsToR320P

[The Liberty Call @TheLibertyCall]

A Practical Tool: Memorization That Lasts
Memorization works best when it is repeated, patterned, and reinforced.

The Tool: Store Truth Through Pattern and Repetition
Choose one piece of truth worth carrying—Scripture first, then other God-honoring wisdom—and commit to it using one or more of these approaches:

1. Repetition Over Time
Short, daily repetition compounds. Five minutes every day outlasts occasional intensity.

2. Patterned Memory
Truth with rhythm, cadence, or poetic structure sticks longer. God designed us to remember patterns.

3. Musical Memory (Including AI Tools)
Music activates multiple parts of the brain at once. This is not new—God’s people have always sung truth to remember it. Psalms were written to be carried through song.

Modern tools simply lower the barrier.
Using AI to set Scripture or truth to music isn’t novelty—it’s modern psalmody. If a song helps you retain truth, use it. If it distracts, set it aside. The tool serves the discipline, not the other way around.

4. Spoken Recall
Say it out loud. Recite it while walking, driving, or resting. Truth spoken is truth strengthened.
Memorization is not about volume or performance.
It is about what you return to when life presses hard.

Choose wisely.
Start small.
Repeat faithfully.
Carry truth where it cannot be taken.
This is a tool, not a rule.
Faithfulness is the aim, not flawless execution.

With my work at The White Rose Resistance I must have a head full of talks and scripture ready to go. Here's a tool I created that I use regularly. I hope it helps you as well. https://t.co/aLdy4UZgHQ

[Clover Carroll @CloverCarroll]

Watch this

[The Liberty Call @TheLibertyCall]

Proud dad moment on The Liberty Call 🔥
My son Cooper just competed against at a recent speech and debate tournament and delivered a powerful call for Boldness in the Church.
He challenges weak pastors afraid to address abortion, pornography & gay marriage. Sword AND trowel. No more silence.
Then he shares his testimony: diagnosed at 10 with Friedreich’s ataxia, now in a wheelchair — yet he refuses victimhood. This life is a test. He’s living boldly for Christ’s glory.
“Those who live small die small.” — Sophie Scholl
Watch the full episode now. The next generation is rising.
Link in bio / comments 👇
Christ is King.
#TheLibertyCall #BoldnessInTheChurch #ChristianCourage #WhiteRoseResistance #ChristIsKing #thewhiteroseresistance @whiterose_life

[Clover Carroll @CloverCarroll]

@Biblicalman This isn’t some hidden “gotcha” your pastor is scared of. It’s a classic example of why we compare parallel passages in the Old Testament and account for how ancient texts were hand-copied for centuries before printing.

[Clover Carroll @CloverCarroll]

@Protestia Agreed

[Clover Carroll @CloverCarroll]

@jamestalarico Joshua Haymes is not Pete Hegseth’s pastor.

[Clover Carroll @CloverCarroll]

Chuck Norris has passed away. When I was a kid I studied the Chuck Norris method of karate. Some of the first discipline I ever experienced. He was a true hero, a man of faith in Christ, and a true Texas Legend. #chucknorris

[Clover Carroll @CloverCarroll]

@DrFrankTurek Psalms 139:13, Proverbs 31:8, Proverbs 24:11

[Clover Carroll @CloverCarroll]

@RealCandaceO Candice, you are so silly 🤪

[The Liberty Call @TheLibertyCall]

This has been a long time coming. Let’s see if it passes.